Scarfo L, Ferreri AJ, Ghia P. Chronic lymphocytic leukaemia. Crit Rev Oncol Hematol. 2016;104:169–82.

Article  PubMed  Google Scholar 

Nie Y, Yun X, Zhang Y, Wang X. Targeting metabolic reprogramming in chronic lymphocytic leukemia. Exp Hematol Oncol. 2022;11(1):39.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Currie E, Schulze A, Zechner R, Walther TC, Farese RV Jr. Cellular fatty acid metabolism and cancer. Cell Metab. 2013;18(2):153–61.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Martin-Perez M, Urdiroz-Urricelqui U, Bigas C, Benitah SA. The role of lipids in cancer progression and metastasis. Cell Metab. 2022;34(11):1675–99.

Article  CAS  PubMed  Google Scholar 

Thurgood LA, Best OG, Rowland A, Lower KM, Brooks DA, Kuss BJ. Lipid uptake in chronic lymphocytic leukemia. Exp Hematol. 2022;106:58–67.

Article  CAS  PubMed  Google Scholar 

Smolewski P, Robak T. Current treatment of refractory/relapsed chronic lymphocytic leukemia: a focus on novel drugs. Acta Haematol. 2021;144(4):365–79.

Article  CAS  PubMed  Google Scholar 

Zhang J, Lu X, Li J, Miao Y. Combining BTK inhibitors with BCL2 inhibitors for treating chronic lymphocytic leukemia and mantle cell lymphoma. Biomark Res. 2022;10(1):17.

Article  PubMed  PubMed Central  Google Scholar 

Nguyen PH, Niesen E, Hallek M. New roles for B cell receptor associated kinases: when the B cell is not the target. Leukemia. 2019;33(3):576–87.

Article  CAS  PubMed  Google Scholar 

Koike S, Keino-Masu K, Ohto T, Masu M. The N-terminal hydrophobic sequence of autotaxin (ENPP2) functions as a signal peptide. Genes Cells. 2006;11(2):133–42.

Article  CAS  PubMed  Google Scholar 

Nishimasu H, Ishitani R, Aoki J, Nureki O. A 3D view of autotaxin. Trends Pharmacol Sci. 2012;33(3):138–45.

Article  CAS  PubMed  Google Scholar 

Reeves VL, Trybula JS, Wills RC, Goodpaster BH, Dube JJ, Kienesberger PC, et al. Serum Autotaxin/ENPP2 correlates with insulin resistance in older humans with obesity. Obesity (Silver Spring). 2015;23(12):2371–6.

Article  CAS  PubMed  Google Scholar 

Rancoule C, Dusaulcy R, Treguer K, Gres S, Attane C, Saulnier-Blache JS. Involvement of autotaxin/lysophosphatidic acid signaling in obesity and impaired glucose homeostasis. Biochimie. 2014;96:140–3.

Article  CAS  PubMed  Google Scholar 

Sioletic S, Czaplinski J, Hu L, Fletcher JA, Fletcher CD, Wagner AJ, et al. c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas. J Pathol. 2014;234(2):190–202.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Drosouni A, Panagopoulou M, Aidinis V, Chatzaki E. Autotaxin in breast cancer: role, epigenetic regulation and clinical implications. Cancers (Basel). 2022;14(21):5437.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kaffe E, Magkrioti C, Aidinis V. Deregulated lysophosphatidic acid metabolism and signaling in liver cancer. Cancers (Basel). 2019;11(11):1626.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Quan M, Cui JJ, Feng X, Huang Q. The critical role and potential target of the autotaxin/lysophosphatidate axis in pancreatic cancer. Tumour Biol. 2017;39(3):1010428317694544.

Article  PubMed  Google Scholar 

Li Y, Zhang L, Xu T, Zhao X, Jiang X, Xiao F, et al. Aberrant ENPP2 expression promotes tumor progression in multiple myeloma. Leuk Lymphoma. 2022;63(4):963–74.

Article  CAS  PubMed  Google Scholar 

Yu C, Luo X, Zhan X, Hao J, Zhang L, YB LS, et al. Comparative metabolomics reveals the metabolic variations between two endangered Taxus species (T. fuana and T. yunnanensis) in the Himalayas. BMC Plant Biol. 2018;18(1):197.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li Y, Fang J, Qi X, Lin M, Zhong Y, Sun L, et al. Combined analysis of the fruit metabolome and transcriptome reveals candidate genes involved in flavonoid biosynthesis in Actinidia arguta. Int J Mol Sci. 2018;19(5):1471.

Article  PubMed  PubMed Central  Google Scholar 

Hallek M, Cheson BD, Catovsky D, Caligaris-Cappio F, Dighiero G, Dohner H, et al. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on chronic lymphocytic leukemia updating the National Cancer Institute-Working Group 1996 guidelines. Blood. 2008;111(12):5446–56.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Han Y, Hu X, Yun X, Liu J, Yang J, Tian Z, et al. Nucleolar and spindle associated protein 1 enhances chemoresistance through DNA damage repair pathway in chronic lymphocytic leukemia by binding with RAD51. Cell Death Dis. 2021;12(11):1083.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hu X, Han Y, Liu J, Wang H, Tian Z, Zhang X, et al. CTP synthase 2 predicts inferior survival and mediates DNA damage response via interacting with BRCA1 in chronic lymphocytic leukemia. Exp Hematol Oncol. 2023;12(1):6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang Y, Zhou X, Li Y, Xu Y, Lu K, Li P, et al. Inhibition of maternal embryonic leucine zipper kinase with OTSSP167 displays potent anti-leukemic effects in chronic lymphocytic leukemia. Oncogene. 2018;37(41):5520–33.

Article  CAS  PubMed  Google Scholar 

Keerthana CK, Rayginia TP, Shifana SC, Anto NP, Kalimuthu K, Isakov N, et al. The role of AMPK in cancer metabolism and its impact on the immunomodulation of the tumor microenvironment. Front Immunol. 2023;14:1114582.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Avsec D, Jakos Djordjevic AT, Kanduser M, Podgornik H, Skerget M, Mlinaric-Rascan I. Targeting autophagy triggers apoptosis and complements the action of venetoclax in chronic lymphocytic leukemia cells. Cancers (Basel). 2021;13(18):4557.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Verrelli D, Dallera L, Stendardo M, Monzani S, Pasqualato S, Giorgio M, et al. Hydroxycitric acid inhibits chronic myelogenous leukemia growth through activation of AMPK and mTOR pathway. Nutrients. 2022;14(13):2669.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sah JP, Hao NTT, Han X, Tran TTT, McCarthy S, Oh Y, et al. Ectonucleotide pyrophosphatase 2 (ENPP2) plays a crucial role in myogenic differentiation through the regulation by WNT/β-Catenin signaling. Int J Biochemi Cell Biol. 2020;118:105661.

Article  CAS  Google Scholar 

Prieto D, Seija N, Uriepero A, Souto-Padron T, Oliver C, Irigoin V, et al. LPL protein in chronic lymphocytic leukaemia have different origins in mutated and unmutated patients. Advances for a new prognostic marker in CLL. Br J Haematol. 2018;182(4):521–5.

Article  CAS  PubMed  Google Scholar 

Rozovski U, Grgurevic S, Bueso-Ramos C, Harris DM, Li P, Liu Z, et al. Aberrant LPL expression, driven by STAT3, mediates free fatty acid metabolism in CLL cells. Mol Cancer Res. 2015;13(5):944–53.

Article  CAS  PubMed  PubMed Central